TITLE

In Vivo Characterization of (−)(−)MCL-144 and ()(−)MCL-193: Isomeric, Bivalent Ligands with Mu/Kappa Agonist Properties

AUTHOR(S)
Brian Fulton; John Neumeyer; Jean Bidlack
PUB. DATE
October 2008
SOURCE
Neurochemical Research;Oct2008, Vol. 33 Issue 10, p2142
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Abstract  Once opioid receptor dimers were postulated, a goal has been to synthesize and screen novel opioids, with the hope of furthering our knowledge of the structure-activity relationship of opioid ligands with the opioid receptors. The aim of the current study was to address whether two isomeric bivalent ligands would have pharmacological differences after central administration, in vivo. The two compounds, (−) bis(N-cyclobutylmethyl-morphinan-3-yl) sebacoylate dihydrochloride (MCL-144) and 1−(()N-cyclobutylmethylmorphinan-3-yl)-10-((−) N-cyclobutylmethylmorphinan-3-yl)sebacolyate (MCL-193) are each linked by a 10-carbon chain ester. The active (−) enantiomer for both ligands is 3-hydroxy-N-cyclobutylmethyl morphinan ((−)MCL-101), a N-cyclobutylmethyl analogue of cyclorphan (J Med Chem 43:114–122, 2000). MCL-144 contains two active levo rotatory (−)(−) pharmacophores, while MCL-193 contains one active (−) and one inactive () pharmacophore of MCL-101. In vitro analysis demonstrated that all three compounds, (−)(−)MCL-144, ()(−)MCL-193 and (−)MCL-101 were κ agonists and μ partial agonists. (−)(−)MCL-144 and (−)MCL-101 had much higher affinity for both the μ and κ opioid receptors compared to ()(−)MCL-193. In vivo, (−)(−)MCL-144 and ()(−)MCL-193 produced full dose–response curves, in the 55°C tail-flick test, with each compound having an ED50 value of 3.0 nmol after intracerebroventricular (i.c.v.) administration. The analgesic properties of both compounds were antagonized by the μ-selective antagonist, β-funaltrexamine and the κ-selective antagonist nor-binaltorphimine. Concomitant, i.c.v., administration of either (−)(−)MCL-144 or ()(−)MCL-193 with morphine, did not significantly antagonize morphine-induced antinociception at any dose tested. In antinociceptive tests, (−)(−)MCL-144 and ()(−)MCL-193 had the same pharmacological properties, demonstrating that having two active pharmacophores separated by a 10-carbon spacer group did not increase the antinociceptive efficacy of the compound. Additionally, it was also of interest to compare (−)(−)MCL-145 and (−)(−)MCL-144, as the only difference between these bivalent ligands is the spacer region connecting the two pharmacophores, yet (−)(−)MCL-145 produced an ED50 value 10-fold lower than (−)(−)MCL-144 (ED50 values = 0.3 nmol and 3.0 nmol, respectively).
ACCESSION #
34305530

 

Related Articles

  • SNC 80 and Related d Opioid Agonists. Calderon, S. N.; Coop, A. // Current Pharmaceutical Design;Mar2004, Vol. 10 Issue 7, p733 

    The discovery of the selective delta (d) opioid agonists SNC 80 and BW373U86, which possess a diarylmethylpiperazine structure unique among opioids, was a major advance in the field of d-opioid ligands. Much research has been performed to uncover the structure-activity relationships (SAR) of...

  • Activity cliffs in PubChem confirmatory bioassays taking inactive compounds into account. Hu, Ye; Maggiora, Gerald; Bajorath, Jürgen // Journal of Computer-Aided Molecular Design;Feb2013, Vol. 27 Issue 2, p115 

    Activity cliffs are formed by pairs or groups of structurally similar compounds with significant differences in potency. They represent a prominent feature of activity landscapes of compound data sets and a primary source of structure-activity relationship (SAR) information. Thus far, activity...

  • Structure-Affinity-Relationship Study of Bicyclic s Receptor Ligands. Holl, Ralph; Geiger, Christian; Nambo, Masakazu; Itami, Kenichiro; Schepmann, Dirk; W�nsch, Bernhard // Central Nervous System Agents in Medicinal Chemistry;Sep2009, Vol. 9 Issue 3, p220 

    It was postulated that N6-allyl bicyclic derivatives 1 bind with N-8 at the proton donor site of the s1 receptor and that a substituent in 2-position of the bicyclic framework 1 results in unfavorable steric interactions with the s1 receptor protein. In order to support this hypothesis both...

  • Cigarette smoking and serum lipid and lipoprotein concentrations: an analysis of published data. Craig, Wendy Y.; Palomaki, Glenn E.; Haddow, James E. // BMJ: British Medical Journal (International Edition);3/25/89, Vol. 298 Issue 6676, p784 

    Examines the association between cigarette smoking among adults in the United States. Discussions on the level of serum lipid and lipoprotein concentrations; Significance of dose response effects on heavy smokers; Risk of coronary artery disease for smokers with high cholesterol concentration.

  • Multiple Ligands in Opioid Research. Ballet, Steven; Pietsch, Markus; Abell, Andrew D. // Protein & Peptide Letters;Jul2008, Vol. 15 Issue 7, p668 

    The observation in 1979 that opioid receptors interact, led to the design of bivalent ligands in an attempt to improve selectivity and affinity towards the different subtypes (i.e. μ, δ and κ). Dimers of monovalent "parent" opioid structures have been evaluated and include: (a)...

  • Delay discounting of food and remifentanil in rhesus monkeys. Maguire, David; Gerak, Lisa; France, Charles // Psychopharmacology;Sep2013, Vol. 229 Issue 2, p323 

    Rationale: Drug abuse can be conceptualized as choice between drug and nondrug reinforcers in which drug choice is excessive; factors impacting drug taking can be examined using procedures in which subjects choose between drug and an alternative reinforcer. Objective: This experiment examined...

  • Observation of magneto-chiral dichroism. Rikken, G.L.J.A.; Raupach, E. // Nature;12/4/1997, Vol. 390 Issue 6659, p493 

    Presents research which reported the experimental observation of a magnetochiral optical effect in crystals and a demonstration of its enantioselectivity. Previous research by Arago, Faraday and Pasteur; Manifestations of optical activity in chiral crystals; Importance of the existence of the...

  • Formation of isomorphic Ir[sup 3+] and Ir[sup 4+] octamers and spin dimerization in the spinel Culr[sub 2]S[sub 4]. Radaelli, Paolo G.; Horibe, Y.; Gutmann, Matthias J.; Ishibashi, Hiroki; Chen, C.H.; Ibberson, Richard M.; Koyama, Y.; Yew-San Hor; Kiryukhin, Valery; Sang-Wook Cheong // Nature;3/14/2002, Vol. 416 Issue 6877, p155 

    Examines the formation of isomorphic Ir[sup 3+] and Ir[sup 4+] octamers and spin dimerization in spinel CuIr[sub 2]S[sub 4]. Description on spinel crystallographic structure; Effects of the sudden decrease of electrical conductivity on cooling with loss of localized magnetic moments; Details on...

  • Kappa Receptor Bivalent Ligands. Xuemei Peng; Neumeyer, John L. // Current Topics in Medicinal Chemistry;Feb2007, Vol. 7 Issue 4, p363 

    Bivalent ligands of κ opioid agonists and antagonists, such as norBNI and BNI, are used as tools to elucidate the κ receptor characteristics. Bivalent ligands may also be effective analgesics although none have this far been used clinically. Structure-activity relationships (SAR) and...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics